Press Releases
AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology. MedImmune has also entered into...
Press Releases
3rd Biotechnology World Congress an event by Eureka Science Ltd announced the list of Advisory Board Members
3rd Biotechnology World Congress hosted by Eureka Science Ltd. is a highly reputed event withing the industry. In the year 2014 is is getting conducted from 10th February to 12th February has now announced the list of their Advisory...
Press Releases
6th International Conference on Drug Discovery and Therapy announced the list of Advisory Board Members
6th International Conference on Drug Discovery and Therapy, a highly reputed event withing the sector which is hosted by Eureka Science Ltd. is getting conducted from 10th February to 12th February in the year 2014 announced the list of...
Press Releases
Advanced research instrumentation pioneer Oxford Optronix to exhibit at Neuroscience 2013
Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries will demonstrate its latest innovative products for research professionals at Neuroscience 2013, the 43rd annual meeting of the Society for Neuroscience in...
Press Releases
Garheng Kong Named to LabCorp Board of Directors
Laboratory Corporation of America® Holdings (LabCorp®) today announced that Garheng Kong MD PhD has been appointed to its Board of Directors effective December 1 2013. “We are delighted that Garheng has accepted our invitation to...
Press Releases
Polyplus-transfection and Merck sign a license and supply agreement for PEI-based transfection reagents
Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology and Merck, a leading pharmaceutical, chemical and life science company with total revenues of EUR 11.2 billion in 2012, announce today a global prior use license...
Press Releases
Banook Central Imaging selected by Servier to provide innovative image analysis services based on a combination of RECIST, IrRC and TGR criteria
Banook Central Imaging (Banook CI), a global imaging core lab for drug and device clinical trials, announces today that it has been selected by Servier to assess the potential anti-tumor activity of a novel monoclonal antibody based on the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















